» Articles » PMID: 29632538

Pathogen Recognition by CD4 Effectors Drives Key Effector and Most Memory Cell Generation Against Respiratory Virus

Overview
Journal Front Immunol
Date 2018 Apr 11
PMID 29632538
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Although much is known about the mechanisms by which pathogen recognition drives the initiation of T cell responses, including those to respiratory viruses, the role of pathogen recognition in fate decisions of T cells once they have become effectors remains poorly defined. Here, we review our recent studies that suggest that the generation of CD4 T cell memory is determined by recognition of virus at an effector "checkpoint." We propose this is also true of more highly differentiated tissue-restricted effector cells, including cytotoxic "ThCTL" in the site of infection and T in secondary lymphoid organs. We point out that ThCTL are key contributors to direct viral clearance and T to effective Ab response, suggesting that the most protective immunity to influenza, and by analogy to other respiratory viruses, requires prolonged exposure to antigen and to infection-associated signals. We point out that many vaccines used today do not provide such prolonged signals and suggest this contributes to their limited effectiveness. We also discuss how aging impacts effective CD4 T cell responses and how new insights about the response of aged naive CD4 T cells and B cells might hold implications for effective vaccine design for both the young and aged against respiratory viruses.

Citing Articles

CD4 memory has a hierarchical structure created by requirements for infection-derived signals at an effector checkpoint.

Swain S Front Immunol. 2023; 14:1306433.

PMID: 38152398 PMC: 10751922. DOI: 10.3389/fimmu.2023.1306433.


"An Intrinsic Program Determines Key Age-Associated Changes in Adaptive Immunity that Limit Response to Non-Pathogens.".

Swain S, Kugler-Umana O, Tonkonogy S Front Aging. 2022; 2.

PMID: 35382063 PMC: 8979546. DOI: 10.3389/fragi.2021.701900.


Development of a Mouse Model to Explore CD4 T Cell Specificity, Phenotype, and Recruitment to the Lung after Influenza B Infection.

Rattan A, White C, Nelson S, Eismann M, Padilla-Quirarte H, Glover M Pathogens. 2022; 11(2).

PMID: 35215193 PMC: 8875387. DOI: 10.3390/pathogens11020251.


Exogenous and Endogenous Dendritic Cell-Derived Exosomes: Lessons Learned for Immunotherapy and Disease Pathogenesis.

Elashiry M, Elsayed R, Cutler C Cells. 2022; 11(1).

PMID: 35011677 PMC: 8750541. DOI: 10.3390/cells11010115.


Synergistic effect of non-neutralizing antibodies and interferon-γ for cross-protection against influenza.

Shibuya M, Tamiya S, Kawai A, Hirai T, Cragg M, Yoshioka Y iScience. 2021; 24(10):103131.

PMID: 34622175 PMC: 8482522. DOI: 10.1016/j.isci.2021.103131.


References
1.
Moser J, Gibbs J, Jensen P, Lukacher A . CD94-NKG2A receptors regulate antiviral CD8(+) T cell responses. Nat Immunol. 2002; 3(2):189-95. DOI: 10.1038/ni757. View

2.
Roman E, Miller E, Harmsen A, Wiley J, von Andrian U, Huston G . CD4 effector T cell subsets in the response to influenza: heterogeneity, migration, and function. J Exp Med. 2002; 196(7):957-68. PMC: 2194021. DOI: 10.1084/jem.20021052. View

3.
Jelley-Gibbs D, Brown D, Dibble J, Haynes L, Eaton S, Swain S . Unexpected prolonged presentation of influenza antigens promotes CD4 T cell memory generation. J Exp Med. 2005; 202(5):697-706. PMC: 2212871. DOI: 10.1084/jem.20050227. View

4.
Pasare C, Medzhitov R . Control of B-cell responses by Toll-like receptors. Nature. 2005; 438(7066):364-8. DOI: 10.1038/nature04267. View

5.
Brown D, Dilzer A, Meents D, Swain S . CD4 T cell-mediated protection from lethal influenza: perforin and antibody-mediated mechanisms give a one-two punch. J Immunol. 2006; 177(5):2888-98. DOI: 10.4049/jimmunol.177.5.2888. View